- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04053504
Feasibility Study of Family Teamwork Peer-Delivery (TEAM)
The purpose of this study is to 1) convene African American and Latino Community Coalitions to adapt Family Teamwork (FT) for school-age youth, and integrate FT with the Smart and Secure Children (SSC) program community-based, peer delivery format, 2) identify facilitators and barriers to parental involvement in diabetes management for African American and Latino parents of children (5-9 years) with T1D to refine, with Community Coalitions the adapted and integrated Family Teamwork- Peer Delivery (FT-P), and 3) evaluate the feasibility, satisfaction, and preliminary outcomes of the FT-P program among African American and Latino parents of school-aged children (5-9 years) withT1D.
A randomized pilot trials will be conducted with African American and Latino families to examine the feasibility, parent satisfaction, and preliminary outcomes of FT-P. Families will be stratified by race/ethnicity, age, and HbA1c strata, and randomized to FT-P plus standard diabetes care or to standard diabetes care alone after completion of baseline assessment using a random numbers table generated by a program created through Baylor College of Medicine's Institute for Clinical Training and Research data management specialists.
연구 개요
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Texas
-
Houston, Texas, 미국, 77030
- Texas Children's Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Primary caregiver of a child ages 5-10 years with type 1 diabetes as defined by the American Diabetes Association criteria
- Having a child with diabetes duration of >1 year
- Self-identified African American or Latino race/ethnicity
- Fluent in English
- Not planning to leave the geographic area during the study
Exclusion Criterion:
• Not fluent in English
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Intervention
Behavioral intervention delivered by parent peer leaders.
|
Children with T1D and their parent will participate in 6 in-person FT-P group sessions during a 12-month period.
Parents will also participate in monthly telephone support calls with a Parent Leader during the 12-month intervention period.
|
|
간섭 없음: Standard Care
Standard diabetes care
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Intervention Acceptability: Treatment Evaluation Inventory
기간: Immediately post-intervention
|
Treatment Evaluation Inventory
|
Immediately post-intervention
|
|
Study Enrollment Rate
기간: Pre-Randomization
|
Enrollment rate calculated from data obtained from recruitment logs
|
Pre-Randomization
|
|
Study Attrition Rate
기간: 12 months
|
Study attrition will be calculated from study logs
|
12 months
|
|
Monthly Intervention Calls Completed by Parent Leaders
기간: 12 months
|
Percentage of monthly intervention calls completed by Parent Leaders will be determined from study logs
|
12 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in Rate of Average Blood Glucose
기간: Change from baseline at 12 months
|
Hemoglobin A1C from medical record
|
Change from baseline at 12 months
|
|
Change in Frequency of Adherence
기간: Change from baseline at 12 months
|
Frequency of blood glucose monitoring obtained from blood glucose meter and the Diabetes Self-Management Questionnaire
|
Change from baseline at 12 months
|
|
Change in Level of Child Diabetes Quality of Life: Pediatric Quality of Life Diabetes Module
기간: Change from baseline at 12 months
|
Pediatric Quality of Life Total Cumulative Scale (scores range from 0-132 with higher scores indicating worse quality of life)
|
Change from baseline at 12 months
|
|
Change in Level of Parent involvement in diabetes management tasks
기간: Change from baseline at 12 months
|
The Diabetes Family Responsibility Questionnaire (scores range from 17-51 with lower scores indicating parent in primarily responsible for diabetes management)
|
Change from baseline at 12 months
|
|
Change in Level of Parent self-efficacy
기간: Change from baseline at 12 months
|
Parental Self-Efficacy for Diabetes Management questionnaire scores range from 8-40 with higher scores indicating higher self-efficacy)
|
Change from baseline at 12 months
|
|
Change in Level of Parent diabetes emotional burden
기간: Change from baseline at 12 months
|
Problem Areas in Diabetes Revised for Parents (scores range from 0-72 with higher scores indicating less emotional burden)
|
Change from baseline at 12 months
|
|
Change in Level of Parent Depressive Symptoms
기간: Change from baseline at 12 months
|
The Center for Epidemiological Depression Studies-Depression scale (scores range from 12-48 with higher scores indicating more depressive symptoms)
|
Change from baseline at 12 months
|
|
Change in Level of Parent Social Support
기간: Change from baseline at 12 months
|
2-way Social Support Scale total score (scores range from 0-100 with higher scores indicating more giving and receiving of social support)
|
Change from baseline at 12 months
|
|
Change in Degree of Impact of diabetes on the family system
기간: Change from baseline at 12 months
|
Diabetes Family Impact Scale (scores range from 0-56 with higher scores indicating greater impact of diabetes on the family)
|
Change from baseline at 12 months
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Ashley M Butler, PhD, Baylor College of Medicine
간행물 및 유용한 링크
유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
기타 연구 ID 번호
- H-40380
- DP3DK113236 (미국 NIH 보조금/계약)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .